A course intravenous injection of dissolved ozone to patients with rapidly progressing lung tuberculosis associated with diabetes mellitus in resistance to antituberculous drugs for 3-4 weeks eliminates this resistance and reduces bacterial discharge including polyresistant strains (MDR-tuberculosis). The percentage of closed caverns significantly increased. Mechanisms of etiopathogenic impact of parenteral dissolved ozone are discussed.